Na ch der Fusion DARA BioSciences ehem. Point Therapeutics & DARA - 500 Beiträge pro Seite

[Biotechspezialx]

DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
Tuesday February 12, 4:15 pm ET

RALEIGH, N.C. and WELLESLEY HILLS, Mass., Feb. 12 / -- DARA BioSciences, Inc. ("DARA") and Point Therapeutics, Inc. ("Point") (Nasdaq: POTP - News) announced the consummation of their merger transaction, effective as of the close of business on February 12, 2008.

ADVERTISEMENT
The merger was completed after approval by the respective stockholders of DARA and Point. Immediately prior to the consummation of the merger, Point effected a reverse stock split of its common stock pursuant to which each 40 shares of Point common stock issued and outstanding was converted into one share of Point common stock. As a result of the merger, DARA stockholders will receive 1.031406 shares of Point common stock for each share of DARA common stock and preferred stock held immediately prior to the transaction.

In making the announcement, DARA's Chairman Richard A. Franco, Sr., commented, "We are pleased to have completed this transaction and appreciate the confidence of the stockholders of DARA and Point as evidenced by their votes."

Upon consummation of the merger, DARA became a wholly-owned subsidiary of Point, and Point changed its name to DARA BioSciences, Inc. The combined company's common stock will continue to trade on the NASDAQ Capital Market under the symbol "DARA ". Additionally, the Board of Directors and executive officers of DARA will lead the combined company.

[habnurwenig]

Na, dann schauen wir mal, was unser neues Unternehmen so macht....

[osterhase1]

Respekt!
Ihr habt aus einen dollar fümf gemacht

[osterhase1]

Ach...kann jemand hier den RT chart rein setzen?
...bitte

[habnurwenig]

Hmm, was ist denn gestern hier passiert? nach so viel rot mal grün?

[habnurwenig]

Sagt mal, bin ich der einzige, der nicht die Aktie vor dem Merger abgestossen hat? Würde mich freuen, wenn noch andere Investierten mal was sagen würden....

[habnurwenig]

Mitteilung vom 25.3.2008


DARA: CSO Dr. John Didsbury Named President and COO


By Fain Hughes, [e-mail]

DARA BioSciences, Inc. (DARA) announced the appointment of John Didsbury, Ph.D. as President and Chief Operating Officer. Dr. Didsbury has served as DARA's Chief Scientific Officer since November 2006. Dr. Didsbury previously served as President and CEO of Nuada Pharmaceuticals, Inc. Dr. Didsbury replaces Richard A. Franco, who notified the Board of Directors on March 21, 2008 of his decision to resign.